In the last years it splut twice which made the OS and float bigger while it did that, it kept shorting. I keot track of this stock however, i bought this at .0217 and sold at .096 and then rebought all again @ .051. Havent sold it ever since then, .205 is still not enough. June 23rd 2017 the clinical trials got approved and waiting for trial 3. Either or a buy out or a JV will happen this stock is still worth to much money.